SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-004807
Filing Date
2020-03-26
Accepted
2020-03-26 16:31:20
Documents
67
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 843999
2 ex4-3.htm EX-4.3 16663
3 ex21-1.htm EX-21.1 7956
4 ex23-1.htm EX-23.1 5160
5 ex31-1.htm EX-31.1 18893
6 ex31-2.htm EX-31.2 18973
7 ex32-1.htm EX-32.1 8437
8 ex32-2.htm EX-32.2 7978
  Complete submission text file 0001493152-20-004807.txt   4127871

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE prph-20191231.xml EX-101.INS 648378
10 XBRL SCHEMA FILE prph-20191231.xsd EX-101.SCH 58329
11 XBRL CALCULATION FILE prph-20191231_cal.xml EX-101.CAL 65439
12 XBRL DEFINITION FILE prph-20191231_def.xml EX-101.DEF 161030
13 XBRL LABEL FILE prph-20191231_lab.xml EX-101.LAB 384437
14 XBRL PRESENTATION FILE prph-20191231_pre.xml EX-101.PRE 261931
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21617 | Film No.: 20746470
SIC: 2834 Pharmaceutical Preparations